What is the most recent earnings date for EXAS stock?
EXACT SCIENCES CORP (EXAS) last reported earnings on 2/13/2026.
EXACT SCIENCES CORP (EXAS) Earnings History & Surprises
NASDAQ:EXAS • US30063P1057
Current stock price
104.91 USD
+0.99 (+0.95%)
At close:
104.947 USD
+0.04 (+0.04%)
After Hours:
EXAS Earnings overview
Past quarterly earnings results for EXACT SCIENCES CORP (EXAS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.15
- Revenue Estimate
- 856.19M
Last Reported
Most Recent- Release Date
- Feb 13, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.38
- EPS Surprise
- -462.34%
- Revenue Surprise
- 0.03%
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.38 | -0.07 | -462.34% | 91.86% | 878.381M | 878.11M | 0.03% | 23.12% |
| Q3 2025 | -0.10 | -0.07 | -40.06% | 52.38% | 850.739M | 826.38M | 2.95% | 20.05% |
| Q2 2025 | -0.01 | -0.18 | 94.53% | 88.89% | 811.085M | 790.16M | 2.65% | 15.99% |
| Q1 2025 | -0.54 | -0.39 | -39.07% | 10.00% | 706.785M | 702.41M | 0.62% | 10.86% |
| Q4 2024 | -4.67 | -0.31 | -1,391.93% | -1,629.63% | 713.424M | 715.33M | -0.27% | 10.29% |
| Q3 2024 | -0.21 | -0.21 | 0.95% | - | 708.655M | 732.02M | -3.19% | 12.78% |
| Q2 2024 | -0.09 | -0.33 | 72.60% | 80.00% | 699.264M | 703.8M | -0.64% | 12.41% |
| Q1 2024 | -0.60 | -0.47 | -26.50% | -42.86% | 637.524M | 639.91M | -0.37% | 5.82% |
| Q4 2023 | -0.27 | -0.47 | 42.36% | 62.50% | 646.885M | 651.58M | -0.72% | 16.98% |
| Q3 2023 | 0.00 | -0.49 | 100.00% | 100.00% | 628.338M | 629.14M | -0.13% | 20.12% |
| Q2 2023 | -0.45 | -0.52 | 13.42% | 45.78% | 622.093M | 612.14M | 1.63% | 19.27% |
| Q1 2023 | -0.42 | -0.77 | 45.29% | 59.62% | 602.45M | 554.33M | 8.68% | 23.81% |
| Q4 2022 | -0.72 | -0.85 | 15.78% | 43.75% | 553M | 538.79M | 2.64% | 16.72% |
| Q3 2022 | -0.84 | -1.10 | 23.92% | 13.40% | 523.1M | 512.99M | 1.97% | 14.61% |
| Q2 2022 | -0.83 | -1.09 | 23.86% | 19.42% | 521.6M | 507.45M | 2.79% | 19.96% |
| Q1 2022 | -1.04 | -1.12 | 7.07% | -477.78% | 486.6M | 470.94M | 3.33% | 21.01% |
| Q4 2021 | -1.28 | -1.06 | -20.50% | 54.12% | 473.8M | 457.98M | 3.45% | 1.61% |
| Q3 2021 | -0.97 | -0.87 | -11.42% | -1,285.71% | 456.4M | 438.63M | 4.05% | 11.75% |
| Q2 2021 | -1.03 | -0.78 | -32.19% | -41.10% | 434.8M | 429.14M | 1.32% | 61.70% |
| Q1 2021 | -0.18 | -1.05 | 82.85% | 74.65% | 402.1M | 396.34M | 1.45% | 15.61% |
| Q4 2020 | -2.79 | -0.23 | -1,130.40% | - | 466.3M | 455.15M | 2.45% | - |
| Q3 2020 | -0.07 | -0.53 | 86.78% | - | 408.4M | 344.12M | 18.68% | - |
| Q2 2020 | -0.73 | -0.64 | -13.65% | - | 268.9M | 232.99M | 15.41% | - |
| Q1 2020 | -0.71 | -0.60 | -18.03% | - | 347.8M | 356.11M | -2.33% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-111.73%
Max EPS beat (4)
94.53%
Min EPS beat (4)
-462.34%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
1.56%
Max Revenue beat (4)
2.95%
Min Revenue beat (4)
0.03%
Analysis
In the last 4 quarters, EXAS has beaten EPS estimates in 1 out of 4 releases
EXAS has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, EXAS reported -111.7% below the EPS estimates on average.
In the last 4 quarters, EXAS has beaten the revenue estimates by 1.6% on average.
Related analysis
EXACT SCIENCES CORP / EXAS Earnings FAQ
Did EXACT SCIENCES CORP (EXAS) beat earnings estimates last quarter?
EXACT SCIENCES CORP (EXAS) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often EXACT SCIENCES CORP beats earnings estimates?
In the last 4 quarters, EXACT SCIENCES CORP (EXAS) has beaten EPS estimates in 1 out of 4 releases.